Puremed Pharma Private Limited

Puremed Pharma Private Limited - chemicals in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
CIN U52311MH2016PTC272363 Incorporated 25 January 2016 ROC Nagpur HQ Nagpur, Maharashtra, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2022
₹13.35 Lakh
▲ 15% YoY
Net profit · FY 2022
₹38,861
Net margin 2.9%
EBITDA · FY 2022
₹45,817
EBITDA margin 3.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹9.5 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings

About Puremed Pharma Private Limited

Data last updated:

Puremed Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 25 January 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U52311MH2016PTC272363. Its GSTIN is 27AAICP5158M1ZT (Maharashtra).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yashwant Gopalrao Lanjewar and Asha Yashwant Lanjewar.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C/O. Rajesh Waghmare House No.5 Gopal Nagar, Nagpur, Maharashtra, India – 440022.

As per the financials filed for FY 2022, the company reported a revenue of ₹13.35 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹38,861 (net margin 2.9%) and EBITDA of ₹45,817 (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 19% over five years.

As per MCA filings, the company has open charges of ₹9.5 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Puremed Pharma Private Limited
CIN U52311MH2016PTC272363
Registration Number 272363
Incorporation Date 25 January 2016
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
Key People
Yashwant Gopalrao Lanjewar Director Asha Yashwant Lanjewar Director Narayan Jaydev Balpande Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    C/O. Rajesh Waghmare House No.5 Gopal Nagar, Nagpur, Maharashtra, India – 440022
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
Comprehensive company report
Puremed Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Puremed Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Puremed Pharma Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Puremed Pharma Private Limited

The main business activity of Puremed Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Puremed Pharma Private Limited FY 2022 filings available

Puremed Pharma Private Limited reported revenue of ₹13.35 Lakh (up 15% YoY) for FY 2022.

Revenue · FY 2022
₹13.35 Lakh ▲ 15%
Net profit · FY 2022
₹38,861 margin 2.9%
EBITDA · FY 2022
₹45,817 margin 3.4%

Compounded Annual Growth Rate (CAGR) of Puremed Pharma Private Limited

Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 33%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 34%
5 years · compounded
▼ 1%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 15% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Puremed Pharma Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹45,817••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹38,861••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Puremed Pharma Private Limited

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin3.4%••••••••••••••••
Net Profit Margin2.9%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Puremed Pharma are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Puremed Pharma Private Limited

Puremed Pharma has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Yashwant Gopalrao LanjewarDirector26 May 20215 Years 4 MonthsCurrent
Asha Yashwant LanjewarDirector25 Jan 201610 Years 8 MonthsCurrent
Narayan Jaydev BalpandeDirector25 Jan 201610 Years 8 MonthsCurrent
View all directors

Peer Comparison of Puremed Pharma Private Limited

Puremed Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Expius Exports Private Limited₹13.35 Lakh (FY 2020)••••••••-44.0%••••Sundargarh, Odisha, India
Digiciti Online Imc (OPC) Private Limited₹13.35 Lakh (FY 2021)••••••••-30.0%••••Chandigarh, India
Rasili Enterprises Private Limited₹13.35 Lakh (FY 2024)••••••••-64.0%••••New Delhi, Delhi, India
Jitendra Sports Private Limited₹13.35 Lakh (FY 2024)••••••••109.0%••••Vadodara, Gujarat, India
Lahthi Trends Private Limited₹13.35 Lakh (FY 2024)••••••••••••Kolkata, West Bengal, India
Puremed Pharma Private Limited this company₹13.35 Lakh (FY 2022)••••••••15.0%••••Nagpur, Maharashtra, India
Vira Biologicals Private Limited₹13.34 Lakh (FY 2023)••••••••••••Hyderabad, Telangana, India
B.S. Sethi and Sons Motors Private Limited₹13.34 Lakh (FY 2019)••••••••3.0%••••New Delhi, Delhi, India
Novatech Energie Systech Private Limited₹13.34 Lakh (FY 2024)••••••••2417.0%••••Vadodara, Gujarat, India
Trillion Tradelink Private Limited₹13.34 Lakh (FY 2025)••••••••-3.0%••••Kolkata, West Bengal, India
Kurane Enterprises Private Limited₹13.34 Lakh (FY 2019)••••••••567.0%••••Miraj, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Puremed Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Puremed Pharma Private Limited

Puremed Pharma Private Limited is audited by VNV & CO. for the financial year 2017.

NameStatusAppointment DateCessation Date
VNV & CO.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Puremed Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Puremed Pharma Private Limited

Open charges
₹9.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Bank of India₹0.10 Cr
Latest charge details
DateLenderAmountStatus
09 Jun 2016Bank of India₹9.5 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Puremed Pharma Private Limited

Employment history and EPFO contributions of people linked to Puremed Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Puremed Pharma Private Limited

Puremed Pharma Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Yashwant Gopalrao Lanjewar was appointed as Director on 26 May 2021.

AGM
Puremed Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Puremed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Nagpur.
Appointed
Yashwant Gopalrao Lanjewar was appointed as Director.
Charges
A charge with Bank Of India amounted to Rs. 9.50 Lakh with Charge ID 100033975 was registered on 09 Jun 2016.
Appointed
Asha Yashwant Lanjewar was appointed as Director.
Appointed
Narayan Jaydev Balpande was appointed as Director.
Incorporation
25 Jan 2016
Puremed Pharma Private Limited was registered on 25 Jan 2016 with Roc Nagpur & aged 10 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Puremed Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Puremed Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Puremed Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Puremed Pharma Private Limited

Puremed Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAICP5158M1ZTMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Puremed Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Puremed Pharma Private Limited

Puremed Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 25 January 2016 (10+ years old) and is registered under CIN U52311MH2016PTC272363.

Puremed Pharma reported revenue of ₹13.35 Lakh for FY 2022 (up 15% YoY).

Puremed Pharma has 3 current directors:

Puremed Pharma reported a net profit of ₹38,861 (net margin 2.9%) and EBITDA of ₹45,817 (EBITDA margin 3.4%) for FY 2022, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Puremed Pharma is 33% over three years and 19% over five years. In the latest year (FY 2022) revenue rose 15%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Puremed Pharma is 27AAICP5158M1ZT, registered in Maharashtra.

The CIN (Corporate Identification Number) of Puremed Pharma is U52311MH2016PTC272363. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Puremed Pharma was incorporated on 25 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Nagpur.

The peers of Puremed Pharma by revenue are Expius Exports Private Limited, Digiciti Online Imc (OPC) Private Limited, Rasili Enterprises Private Limited, Jitendra Sports Private Limited, Lahthi Trends Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).

Yashwant Gopalrao Lanjewar was appointed as Director on 26 May 2021. Asha Yashwant Lanjewar was appointed as Director on 25 Jan 2016. Narayan Jaydev Balpande was appointed as Director on 25 Jan 2016.

The registered office of Puremed Pharma is at CO. Rajesh Waghmare House No.5 Gopal Nagar, Nagpur, Maharashtra, India – 440022.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available